Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.6737
-0.0165 (-2.39%)
Feb 20, 2026, 12:41 PM EST - Market open
Oragenics Market Cap
Oragenics has a market cap or net worth of $2.87 million as of February 20, 2026. Its market cap has decreased by -17.90% in one year.
Market Cap
2.87M
Enterprise Value
-8.07M
1-Year Change
-17.90%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $1.60M to $2.87M, an increase of 79.59%. That is a compound annual growth rate of 2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 2.90M | -12.12% |
| Dec 31, 2025 | 3.30M | -26.67% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.50% |
| Dec 31, 2009 | 27.20M | 186.32% |
| Dec 31, 2008 | 9.50M | -17.39% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.25% |
| Dec 31, 2004 | 55.30M | 3,356.25% |
| Feb 27, 2004 | 1.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.68M |
| Enveric Biosciences | 3.36M |
| Propanc Biopharma | 3.21M |
| HCW Biologics | 3.12M |
| SciSparc | 2.87M |
| Artelo Biosciences | 2.85M |
| Adial Pharmaceuticals | 2.84M |
| XORTX Therapeutics | 2.70M |